Introduction {#s1}
============

One of the most powerful techniques for characterizing gene function is to generate transgenic animals in which an epitope tag such as GFP has been fused to the gene at its normal genomic location ([@bib20]; [@bib16]; [@bib21]). These tagged proteins are extremely useful as they permit determination of protein localization in vivo as well as conditional, tissue specific, temporal and reversible removal of the tagged proteins ([@bib17]). However, previous methods for generating protein trap alleles in *Drosophila* have allowed only about 800 genes to be successfully tagged ([@bib13]; [@bib4]; [@bib19]; [@bib2]; [@bib15]).

We previously developed a flexible system for engineering the *Drosophila* genome using the Minos-Mediated Integration Cassette (MiMIC) transposable element. We generated 15,660 strains with a single MiMIC inserted at random within the fly genome and mapped their insertion site ([@bib3]; [@bib22]; [@bib17]). MiMIC carries sequences that function as a gene and protein trap when inserted in the proper orientation in a coding intron. Moreover, its content can be replaced by Recombination-Mediated Cassette Exchange (RMCE) leading to the introduction of any desired DNA, such as an artificial exon that encodes a protein tag. This approach can potentially be used to tag thousands of genes. Currently, 2854 existing insertions are located within the coding introns of 1862 distinct genes ([@bib17]), and MiMIC-like elements can now be placed in any gene of interest by CRISPR ([@bib24]). Unfortunately, the RMCE method needed to convert these insertions into functional protein traps requires embryonic injections of an appropriate donor DNA and screening of many offspring to identify the desired events, a labor and cost-intensive procedure that does not scale easily. We therefore developed a more efficient and economical in vivo genetic tagging methodology that can in principle be used to generate protein trap alleles of all *Drosophila* genes.

Results and discussion {#s2}
======================

We developed a genetic strategy that allows the desired RMCE event to take place efficiently without the need for microinjection. The method uses FLP recombinase to release a genomically integrated DNA flanked by FRT sites into the nucleoplasm where it can efficiently undergo phiC31 integrase-mediated cassette exchange, as shown by [@bib9]. As shown in [Figure 1A](#fig1){ref-type="fig"}, we engineered three donor cassettes, one for each reading frame. The core, which contains a splice acceptor (SA) followed by a (GGS)~4~ flexible linker, multiple tags (EGFP-FlAsH-StrepII-TEVcs-3xFlag {GFSTF}), another (GGS)~4~ flexible linker, and a splice donor (SD), is flanked by two inverted *attB* sites for phiC31-mediated RMCE ([@bib22]). We then cloned this cassette core between tandem FRT sites in a *P-element* transformation vector ([@bib11]). FLP-mediated recombination between the tandem FRT sites excises a circular donor DNA molecule from its initial genetic locus, promoting its efficient recombination with a distal target site ([@bib10]). A mini-white eye color marker gene between our donor cassette and one of the FRT sites allows us to monitor the presence or absence of the donor cassette in FLP recombinase-containing stocks.10.7554/eLife.08469.002Figure 1.Schematic of flippase and phiC31 integrase mediated in vivo protein tagging.(**A**) Flp mediated generation of circular DNA with tag sequences. Donor line carries a source of Flp recombinase and phiC31 integrase, and the core cassette for a specific phase (0, 1, or 2) encoding a (GGS)~4~ flexible linker (L), multiple tags EGFP-FlAsH-StrepII-TEVcs-3xFlag (GFSTF), another (GGS)~4~ flexible linker, and a splice donor (SD), which is flanked by two inverted *attB* and two FRT sites oriented in that same direction. Upon Flp expression, the core is flipped out as a circular DNA containing one FRT site. (**B**) In vivo integration of tag sequence into Minos-Mediated Integration Cassette (MiMIC) locus. At a MiMIC locus in a coding intron, the MiMIC gene trap cassette is replaced by L-EGFP-FlAsH-StrepII-TEVcs-3xFlag-L sequence by phiC31 integrase resulting in loss of *yellow*^*+*^ marker.**DOI:** [http://dx.doi.org/10.7554/eLife.08469.002](10.7554/eLife.08469.002)10.7554/eLife.08469.003Figure 1---source data 1.List of constructs.**DOI:** [http://dx.doi.org/10.7554/eLife.08469.003](10.7554/eLife.08469.003)10.7554/eLife.08469.004Figure 1---source data 2.List of fly strains generated.Stocks \#1 to 6 are stocks that contain the GFSTF construct (phase 0, 1, and 2) for tagging genes/proteins that map to chromosome II and III. Stocks \# 7: FRT cassette maps to chromosome 2 and contains phase 0 construct; \#8: FRT cassette maps to chromosome 2 and contains phase 1 construct; \#9: FRT cassette maps to chromosome 2 and contains phase 2 construct; \#10: FRT cassette maps to chromosome 3 and contains phase 0 construct; \#11: FRT cassette maps to chromosome 3 and contains phase 1 construct; \#12 FRT cassette maps to chromosome 3 and contains phase 2 construct.**DOI:** [http://dx.doi.org/10.7554/eLife.08469.004](10.7554/eLife.08469.004)

We created 6 stocks ([Figure 1---source data 2](#SD2-data){ref-type="supplementary-material"}), each harboring one of the three donor transgenes located on the second or third chromosome, and a heat shock-inducible FLP recombinase and a germ line-expressed phiC31 integrase on the X-chromosome. Because the heat shock-inducible FLP recombinase is somewhat leaky at 18°C, the donor transgene is lost from these stocks at a low frequency, resulting in rare white-eyed flies, which we periodically discard.

To initiate RMCE, we crossed the appropriate donor flies to MiMIC-containing flies and heat shocked the resulting embryos and larvae ([Figure 2](#fig2){ref-type="fig"}). Within the primordial germ cells of some of the embryos and larvae, phiC31 integrase catalyzed recombination between *attB* sites in the donor and *attP* sites in the MiMIC transposon. The positive RMCE events were selected based on the loss of the *y +* marker present in the original MiMIC ([Figure 2](#fig2){ref-type="fig"}). We confirmed the integration and orientation of the donor cassette by PCR as described in [@bib22]. Typically, 50% of the integration events are in the proper orientation.10.7554/eLife.08469.005Figure 2.Crossing scheme for generating EGFP tagged MiMIC lines.Females carrying the hs-FLP and *vasa-phiC31* integrase on the X-chromosome, and the FRT flanked multiple tag (GFSTF) cassette on the II-chromosome are crossed to males carrying a MiMIC insertion in a coding intron of a gene on the III-chromosome. The resulting embryos are heat shocked, and adult progeny with the desired genotype are crossed with flies carrying appropriate balancers. The resulting progeny is screened for the loss of *white*^*+*^ and *yellow*^*+*^ and crossed to flies carrying appropriate balancers to establish stocks, which are then verified by PCR assay.**DOI:** [http://dx.doi.org/10.7554/eLife.08469.005](10.7554/eLife.08469.005)

We observed one to ten RMCE events in 93 out of 113 attempts in our initial trial when we set up 3--7 crosses (Cross 2 in [Figure 2](#fig2){ref-type="fig"}). After PCR screening, 60/93 of the tested MiMICs allowed integration of at least one donor in the proper orientation to tag the endogenous gene ([Supplementary file 1](#SD3-data){ref-type="supplementary-material"}). In summary, we set up 3--7 vials for each starting cross and obtained 60/113 tagged genes. Since the efficiency of RMCE and the ease of detecting yellow^−^ progeny vary between different starting sites, we propose to set up 10--20 vials and to score more progeny to improve the success rate. The method has been found to work for a wide variety of genes including a gene located in a telomeric region (*lethal giant larvae* (*l(2)gl*)), suggesting that there may be few limitations in its applicability.

To ensure that the expression pattern and protein distribution correspond to the endogenous protein, we costained two tagged lines with GFP for which specific monoclonal antibodies are available: Eyes shut (Eys) (mAb 21A6,) and Delta (Dl) (mAb C594.9B) ([Figure 3A](#fig3){ref-type="fig"}). In both cases, the protein recognized by the mAb colocalizes with the GFP and match the described expression patterns ([@bib6]; [@bib12]). Note, however, that the GFP tagged Eys protein is present in the cytoplasm of the photoreceptors and the inter-rhabdomere spaces (IRS) of the photoreceptors, whereas the mAb against Eys mostly localizes to the IRS ([Figure 3A](#fig3){ref-type="fig"}). These data are in agreement with what we previously observed for numerous tagged proteins ([@bib22]; [@bib17]).10.7554/eLife.08469.006Figure 3.Expression of EGFP tagged protein in various tissues.(**A**) Colocalization of GFP tagged proteins with gene specific antibodies: anti-GFP signals (green) show colocalization with anti-Eys (red) in inter-rhabdomere space in adult eye (top panel) and anti-Delta (blue) in L3 eye imaginal disc in bottom panel. Scale bars, 2 μm and 5 μm. (**B**) Examples of EGFP expression pattern in different tissues from third instar larvae: brain; l(2)gl (**A**), Dl (**B**), twins (tws) (**C**), Sap-r (**E**), Rgk3 (**F**), and Hrb98DE (**G**), wing imaginal disc: kay (**D**), hindgut: CG10086 (**H**), and cells of the cuticle: CG5656 (**I**). Scale bars 100 μm. (**A**--**I**, except **G**), 25 μm (**G**). Eys, eyes shut.**DOI:** [http://dx.doi.org/10.7554/eLife.08469.006](10.7554/eLife.08469.006)

We stained third instar larval brains and discs for the 60 tagged gene/proteins. The examples, shown in [Figure 3B](#fig3){ref-type="fig"}, include *lethal (2) giant larvae* (*l(2)gl*) (a), *Delta* (*Dl*) (b), and *twins* (*tws*) (c) whose expression patterns are consistent with published data ([@bib14]; [@bib1]; [@bib5]). Similarly, *kayak/fos* (*kay*) is expressed in wing disc nuclei (d) as described earlier ([@bib23]). The expression pattern of the remaining genes has not been previously described ([Figure 3B](#fig3){ref-type="fig"}): *Saposin-related* (*Sap-r*) is expressed in a subset of cells in larval brain (e), *Rad, Gem/Kir family member 3* (*Rgk3*) is enriched in mushroom body in L3 larval brain (f), *Heterogeneous nuclear ribonucleoprotein at 98DE* (*Hrb98DE*) is expressed in L3 larval brain (g), *CG10086* is expressed in hindgut (h), and *CG5656* is expressed in the cells of the cuticle (i). The expression patterns of all these genes as well as all the genes listed in [Supplementary file 1](#SD3-data){ref-type="supplementary-material"} are documented in the MiMIC RMCE database at <http://flypush.imgen.bcm.tmc.edu/pscreen/rmce/>.

In summary, we developed a genetic tagging strategy that will greatly facilitate the EGFP tagging of nearly 2000 genes that already carry MiMIC insertions ([@bib17]). The same strategies can also be used for tagging genes with other protein tags. In addition, a similar strategy based on *lox* sites instead of *FRT* cassettes has recently been developed to integrate an artificial exon carrying the *GAL4* gene in MiMICs inserted in coding introns ([@bib7]). These insertions are mutagenic but permit the expression of the endogenous wild-type and mutant cDNAs of *Drosophila* as well as other species under the control of UAS. Moreover, these tagging methods can now be combined with CRISPR directed integration of *attP* carrying cassettes similar to MiMIC in coding introns to tag almost every gene in *Drosophila* ([@bib24]).

Material and methods {#s3}
====================

Cloning {#s3-1}
-------

The core cassettes (attB-SA- phase 0/1/2-\[GGS\]~4~-EGFP-FlAsH-StrepII-TEVcs-3xFlag-\[GGS\]~4~-SD-attB) for Phase 0,1, or 2 were excised from pBS-KS-attB1-2-PT-SA-SD-0-EGFP-FlAsH-StrepII-TEVcs-3xFlag, pBS-KS-attB1-2-PT-SA-SD-1-EGFP-FlAsH-StrepII-TEVcs-3xFlag, or pBS-KS-attB1-2-PT-SA-SD-2-EGFP-FlAsH-StrepII-TEVcs-3xFlag as NheI/NsiI fragments and subcloned into *P-element* vector pW35 (DGRC) between PstI/AvrII to create final donor vectors pW35-FRT-attB-SA-phase 0-(GGS)~4~-EGFP-FlAsH-StrepII-TEVcs-3xFlag-(GGS)~4~-SD-attB-white^+^-FRT, pW35-FRT-attB-SA-phase 1-(GGS)~4~-EGFP-FlAsH-StrepII-TEVcs-3xFlag-(GGS)~4~-SD-attB-white^+^-FRT and pW35-FRT-attB-SA-phase 2-(GGS)~4~-EGFP-FlAsH-StrepII-TEVcs-3xFlag-(GGS)~4~-SD-attB-white^+^-FRT.

In vivo tagging {#s3-2}
---------------

Around 15--20 phase-specific homozygous donor females (*P{ry^+t7.2^= hsFLP}12, y^1^w^\*^M{vas-int.B}ZH-2A; P{FRT-attB-*{GFSTF}*-attB(w*^*+*^*)-FRT}; Pri^1^/TM6B, Tb^1^* or *P{ry^+t7.2^ = hsFLP}12, y^1^ w^\*^M{vas-int.B}ZH-2A; S^1^/CyO; P{FRT-attB-{GFSTF}-attB (w*^*+*^*)-FRT})* were crossed with 5--10 males carrying MiMIC insertion in coding intron (*y^1^ w\*; Mi\[MIC* ***y***^***+***^*\] gene*^*MI*^*/Mi\[MIC y*^*+*^*\] gene*^*MI*^ or balancer). Crosses were transferred to new vials every third day and constantly kept at 18°C. Vials with progeny embryos and larvae were heat shocked on day 3, 4, and 5 for 20 minutes at 37°C in a water bath and raised at 25°C. About 5--7 vials with a pool of 5 F1 males with mosaic red eyes and yellow body were crossed with 10--15 virgins of *y*^*1*^*w*^*67c23*^*; In(2LR)Gla, wg*^*Gla−1*^*/SM6a or y*^*1*^*w\*; D/TM6b, Hu, Tb*. Transgenic F2 progeny were screened for loss of *yellow*^*+*^ (yellow-phenotype) and subsequently crossed to virgins of *y*^*1*^*w*^*67c23*^*; In(2LR)Gla, wg*^*Gla−1*^*/SM6a* or *y*^*1*^*w\*; D/TM3,Sb, Tb* to establish stocks. Correct RMCE events were confirmed by PCR assay as described in [@bib17].

Immunostaining {#s3-3}
--------------

Briefly, third instar larvae were dissected for larval brains, imaginal discs, and gut in 1xPBS and fixed in 3.7% formaldehyde for 30 min at room temperature and washed in 0.2% Triton X-100 ([@bib17]). They were then incubated for 1 hr at RT in 10% NGS-PBS-0.2% Triton X-100 and stained with primary antibodies diluted in 10% NGS-PBS-0.2% Triton X-100 overnight at 4°C. The samples were washed and incubated with secondary antibodies for 2 hr at RT. The samples were then washed and mounted in Vectashield (Vector Labs, Burlingame, CA) and imaged with a Zeiss LSM710 confocal microscope and processed using Adobe Photoshop (Adobe Systems Inc., San Jose, CA, USA).

Antibodies used {#s3-4}
---------------

Primary antibodies used: rabbit anti-GFP 1:1000 (Life Technologies, A11122), mouse anti-Delta 1:1000 (C594.9B, DSHB \[[@bib18]\]), and mouse anti-Eys 1:250 (21A6, DSHB \[[@bib8]\]). Secondary antibodies used: Alexa 488 (Invitrogen, Life Technologies, Grand Island, NY), Cy5 and Cy3 conjugated antibodies (Jackson ImmunoResearch, West Grove, PA) were used at 1:500.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for submitting your work entitled "A genetic toolkit for tagging intronic MiMIC containing genes" for peer review at *eLife*. Your submission has been favorably evaluated by K VijayRaghavan (Senior editor), Mani Ramaswami (Reviewing editor), and two reviewers.

The reviewers have discussed the reviews with one another and the Reviewing editor has drafted this decision to help you prepare a revised submission.

Summary:

This Research Advance describes the creation of a genetic toolkit that allows for the (Recombination Mediated Cassette Exchange) RMCE of an integrated exon encoding for GFP with existing MIMIC insertions. This resource bypasses the need for laborious injections and will facilitate the use of MIMIC lines for epitope tagging genes at their endogenous sites. An extension of the recent MiMIC resource that was published in *eLife*, it documents a simplified and streamlined version of converting an intronic MiMIC insertion (containing 2 *attP* sites) into a GFP tagged protein locus without need for the traditional labour-intensive injection approach. The source of the circular donor plasmid that contains both *attB* sites and the GFP cassette is a Flp mediated excision of a transgenic insertion. Transgenic lines for all three reading frames on second and third chromosome together with Flp and phiC31 sources were generated. The successful exchange has been demonstrated for 60 loci.

This RMCE approach provides a significant advance of the former MiMIC resource and can also be used beyond MiMIC, e.g. if the *attP* cassette has been inserted by CRISPR.

Essential revisions:

Several points should be addressed:

1\) [Figure 1](#fig1){ref-type="fig"} appears incorrect: surely the *white*^*+*^ box should be between the *attB* site and the FRT.

2\) In the paragraph starting with "We observed RMCE events...", the sentence "We set up 3-7 vials for each starting cross and this was sufficient to obtain 60/116 (113 or 116) tagged genes." What is meant by (113 or 116)? This paragraph suggests that RMCE is unsuccessful in close to half of the lines tested. Do the authors have any insights into why this may be the case? Is there a common feature amongst the MIMIC lines that failed RMCE?

The authors should provide some idea of how efficient the process is. How many individual events were obtained from the 3-7 starting vials? How many flies were typically screened to get potential recombinants?

3\) In "Since the efficiency of RMCE...", yellow should be replaced by *yellow*^*--*^.

4\) In the same paragraph, the authors should list examples of genes in heterochromatic regions.

5\) Given the utility of newly developed CRISPR/Cas9 techniques, the authors should discuss the strengths of MIMIC system. The case can certainly be made. But the GFP cassettes described here represent only an incremental start. This resource would be greatly enhanced by generating lines with additional tags, as previously described by the authors.

10.7554/eLife.08469.009

Author response

*1)* [*Figure 1*](#fig1){ref-type="fig"} *appears incorrect: surely the* white^+^ *box should be between the* attB *site and the FRT*.

We thank the reviewers for pointing out this error. We made the correction in [Figure 1](#fig1){ref-type="fig"}.

*2) In the paragraph starting with* "*We observed RMCE events...*"*, the sentence* "*We set up 3-7 vials for each starting cross and this was sufficient to obtain 60/116 (113 or 116) tagged genes." What is meant by (113 or 116)? This paragraph suggests that RMCE is unsuccessful in close to half of the lines tested. Do the authors have any insights into why this may be the case? Is there a common feature amongst the MIMIC lines that failed RMCE?*

We thank the reviewers for pointing out this issue. We have deleted the numbers.

*This paragraph suggests that RMCE is unsuccessful in close to half of the lines tested. Do the authors have any insights into why this may be the case? Is there a common feature amongst the MIMIC lines that failed RMCE? The authors should provide some idea of how efficient the process is*.

The RMCE was successful in 82% (93/113) of cases (please see the first sentence of this paragraph). This number includes EGFP cassette insertions in positive and negative orientation. However the probability of getting EGFP inserted in the correct orientation is statistically 50% of total RMCE events. The number 60 is the number of genes for which the EGFP cassette was inserted in the correct orientation resulting in EGFP tagged fusion proteins. Therefore with the current number of crosses (3-7 vials; Cross 2 in [Figure 2](#fig2){ref-type="fig"}) the efficiency is 53% (60/113). This can be increased by setting a greater number of screening crosses (10-20 vials per line) to obtain more RMCE events with insertion in positive orientation. Indeed, we recovered significantly more positive events with 7 crosses than with three crosses.

How many individual events were obtained from the 3-7 starting vials? How many flies were typically screened to get potential recombinants?

We obtained 1-10 RMCE positive individuals after screening a total of 300-700 flies from 3-7 vials.

*3) In* "*Since the efficiency of RMCE...*"*, yellow should be replaced by* yellow^--^.

We have corrected it.

*4) In the same paragraph, the authors should list examples of genes in heterochromatic regions*.

We have included the gene name (*Lethal giant larva (l(2)gl)*) in text.

*5) Given the utility of newly developed CRISPR/Cas9 techniques, the authors should discuss the strengths of MIMIC system. The case can certainly be made. But the GFP cassettes described here represent only an incremental start. This resource would be greatly enhanced by generating lines with additional tags, as previously described by the authors*.

We have modified the last paragraph of the Discussion.

[^1]: These authors contributed equally to this work.
